Spotlight
Partners
Letters
Regarding your Instant Poll (posted on your Web site in October) about whether triptans should go over the counter, they shouldn't. Side effects or overdose reactions are far too severe. But insurance companies should make them more accessible to patients by eliminating preauthorization or quantity control to legitimate patients who have been counseled by a doctor/pharmacist. I personally know some patients who have stopped trying to fill legitimate Rxs for triptans because of all the red tape involved and the length of time to actually get the drug.
Related Videos
Related Content
